# LLMs/AA/AI opportunities?

Chairs: Paulo Bargo & Ning Leng

# Question

What should we be doing to leverage advances in LLMs/AA/AI impact? (at the drug development through to developer efficiency levels)

::: {.callout-warning}

## Missing notes

Content is still coming, an email will be shared once the site is complete.

:::